Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases

Citations Over TimeTop 1% of 2013 papers

Abstract

Parkin is a RING-between-RING E3 ligase that functions in the covalent attachment of ubiquitin to specific substrates, and mutations in Parkin are linked to Parkinson's disease, cancer and mycobacterial infection. The RING-between-RING family of E3 ligases are suggested to function with a canonical RING domain and a catalytic cysteine residue usually restricted to HECT E3 ligases, thus termed 'RING/HECT hybrid' enzymes. Here we present the 1.58 Å structure of Parkin-R0RBR, revealing the fold architecture for the four RING domains, and several unpredicted interfaces. Examination of the Parkin active site suggests a catalytic network consisting of C431 and H433. In cells, mutation of C431 eliminates Parkin-catalysed degradation of mitochondria, and capture of an ubiquitin oxyester confirms C431 as Parkin's cellular active site. Our data confirm that Parkin is a RING/HECT hybrid, and provide the first crystal structure of an RING-between-RING E3 ligase at atomic resolution, providing insight into this disease-related protein.

Related Papers

• → Parkin–phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity(2017)111 cited
• → Ubiquitin and a charged loop regulate the ubiquitin E3 ligase activity of Ark2C(2022)32 cited
• → The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases(2023)26 cited
• → The ubiquitin ligase parkin modulates the execution of autophagy(2011)17 cited
• Regulation of the ubiquitin RING E3 ligase Parkin(2011)